High materiality8/10
Jazz Pharmaceuticals price target raised to $337 from $315 at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises Jazz Pharmaceuticals target to $337 from $315; current price $245.35.
- UBS raises Jazz Pharmaceuticals target to $337; price $245.35; change +0.11
Key facts
- 01
Target: $337
- 02
Posted price: $245.35
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.